Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
About Us
Careers
Videos
Webinars
Press Releases
Whitepapers
Advertising
Site Map
2023
February
01
Sepsis increases heart failure, rehospitalization risks following hospital discharge
SD Biosensor, SJL Partners complete acquisition of Meridian Bioscience
French point-of-care testing firm Biosynex to acquire Chembio Diagnostics for $17.2M
Sherlock Biosciences acquires Sense Biodetection to drive CRISPR-based test adoption
University of Missouri researchers say specific long-COVID symptoms fewer than expected
AstraZeneca, Capitainer to develop biomarker protocols using at-home patient sampling device
Study suggests immune response to anticancer checkpoint inhibitors unaffected by COVID-19 vaccination
Guardant NSCLC biomarker test to incorporate Lunit’s AI-based scoring algorithm
Genetic Technologies, Qiagen forming strategic alliance
Page 1 of 1